Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

PODD Insider Trading

INSULET CORP | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at INSULET CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2019-03-06 03:17 2019-03-01 Abdel-Malek Aiman Officer - EVP & Chief Technology Officer SELL $95.22 1,608 $153,119 23,992 -6.3%
2019-03-06 03:15 2019-03-01 Colleran David Officer - SVP, Secretary and GC OPT+S $94.65 20,975 $1,985,359 30,433 0.0%
2019-03-06 03:06 2019-03-01 Lemoine David A Director SELL $94.29 561 $52,896 10,022 -5.3%
2019-03-01 04:44 2019-02-27 Levitz Michael L Officer - SVP and CFO SELL $92.01 1,350 $124,214 56,651 -2.3%
2019-02-07 00:34 2019-02-05 Colleran David Officer - SVP, Secretary and GC OPT+S $80.72 6,834 $551,640 34,133 0.0%
2019-02-02 01:29 2019-01-31 Colleran David Officer - SVP, Secretary and GC OPT+S $80.00 4,826 $386,080 34,133 0.0%
2018-11-16 00:24 2018-11-14 Colleran David Officer - SVP, Secretary and GC OPT+S $80.41 6,113 $491,546 34,042 0.0%
2018-11-16 00:02 2018-11-14 Abdel-Malek Aiman Officer - EVP & Chief Technology Officer SELL $80.41 602 $48,407 25,551 -2.3%
2018-11-06 00:34 2018-11-01 Petrovic Shacey Officer - President and COO SELL $86.91 1,134 $98,556 86,199 -1.3%
2018-10-17 00:13 2018-10-15 Abdel-Malek Aiman Officer - EVP & Chief Technology Officer SELL $88.58 602 $53,325 26,153 -2.3%
2018-09-19 00:18 2018-09-14 Abdel-Malek Aiman Officer - EVP & Chief Technology Officer SELL $107.99 602 $65,010 26,755 -2.2%
2018-09-06 01:14 2018-09-04 Petrovic Shacey Officer - President and COO SELL $104.26 960 $100,090 87,333 -1.1%
2018-08-16 00:37 2018-08-14 Spears Michael P Officer - SVP, QA and RA SELL $86.08 5,043 $434,113 27,304 -15.6%
2018-08-16 00:26 2018-08-14 Abdel-Malek Aiman Officer - EVP & Chief Technology Officer SELL $86.60 602 $52,133 27,357 -2.2%
2018-06-14 23:45 2018-06-12 Spears Michael P Officer - SVP, QA and RA OPT+S $100.00 7,496 $749,600 35,671 0.0%
2018-06-06 01:01 2018-06-01 Petrovic Shacey Officer - President and COO SELL $94.72 1,067 $101,066 88,293 -1.2%
2018-06-01 00:45 2018-05-30 Spears Michael P Officer - SVP, QA and RA OPT+S $95.00 8,071 $766,745 35,671 0.0%
2018-05-29 23:02 2018-05-24 Spears Michael P Officer - SVP, QA and RA OPT+S $90.00 8,671 $780,390 35,671 0.0%
2018-05-22 23:14 2018-05-18 Spears Michael P Officer - SVP, QA and RA SELL $87.77 7,774 $682,301 35,671 -17.9%
2018-05-16 23:53 2018-05-15 Spears Michael P Officer - SVP, QA and RA SELL $86.64 8,114 $702,999 43,445 -15.7%
2018-05-16 23:33 2018-05-15 Colleran David Officer - SVP, Secretary and GC SELL $86.24 4,956 $427,405 37,139 -11.8%
2018-05-03 01:36 2018-05-01 Lemoine David A Director SELL $84.93 1,084 $92,064 8,398 -11.4%
2018-03-21 01:29 2018-03-16 Thomas Bradley A Officer - EVP Human Resources SELL $85.00 3,500 $297,500 66,828 -5.0%
2018-03-17 01:37 2018-03-15 Alpuche Charles Officer - EVP & Chief Operations Officer SELL $84.65 7,090 $600,169 42,973 -14.2%
2018-03-17 01:32 2018-03-14 Thomas Bradley A Officer - EVP Human Resources SELL $83.81 7,250 $607,623 70,328 -9.3%
2018-03-17 01:25 2018-03-14 Fallon John A. Director SELL $84.10 9,000 $756,913 9,558 -48.5%
2018-03-09 02:47 2018-03-06 Petrovic Shacey Officer - President and COO SELL $76.81 1,319 $101,312 90,017 -1.4%
2018-03-09 02:33 2018-03-06 Lemoine David A Director SELL $76.81 641 $49,235 9,482 -6.3%
2017-11-15 02:03 2017-11-13 MULLEN JAMES C Director BUY $67.45 2,500 $168,633 5,598 +80.7%
2017-09-07 23:55 2017-09-06 Alpuche Charles Officer - EVP, Global Manufacturing BUY $58.08 2,500 $145,212 34,709 +7.8%
2017-05-18 15:29 2017-05-16 Spears Michael P Officer - SVP, QA and RA BUY $40.59 2,500 $101,470 38,055 +7.0%
2017-05-12 15:33 2017-05-11 Hopfield Jessica Director BUY $38.68 2,580 $99,783 15,228 +20.4%
2017-05-12 15:31 2017-05-11 Thomas Bradley A Officer - EVP Human Resources BUY $38.69 3,000 $116,077 63,778 +4.9%
2017-05-02 23:12 2017-05-01 Lemoine David A Director SELL $43.40 1,524 $66,142 7,414 -17.1%
2017-03-14 23:45 2017-03-13 SOMMER REGINA O Director OPT+S $45.00 40,000 $1,800,132 20,330 0.0%
2017-03-09 01:19 2017-03-06 Lemoine David A Director SELL $45.15 1,282 $57,882 8,938 -12.5%
2017-03-04 02:22 2017-03-02 Zakrzewski Joseph S Director OPT+S $46.86 40,000 $1,874,496 27,849 0.0%
2016-12-12 16:40 2016-12-09 Alpuche Charles Officer - SVP, Global Manufacturing BUY $37.70 6,600 $248,802 22,621 +41.2%
2016-12-05 16:36 2016-12-01 Thomas Bradley A Officer - EVP Human Resources BUY $32.45 3,100 $100,595 54,983 +6.0%
2016-12-05 16:37 2016-12-02 SULLIVAN PATRICK J Director, Officer - CEO and Chairman of the Board BUY $33.89 40,000 $1,355,720 261,544 +18.1%
2016-05-27 23:06 2016-05-25 SOMMER REGINA O Director SELL $30.42 8,019 $243,924 20,330 -28.3%
2016-05-19 15:38 2016-05-17 SULLIVAN PATRICK J Director, Officer - President & CEO BUY $27.00 45,000 $1,215,185 217,795 +26.0%
2016-05-16 15:29 2016-05-13 Thomas Bradley A Officer - EVP Human Resources BUY $26.63 2,975 $79,222 51,315 +6.2%
2016-05-07 01:31 2016-05-05 Thomas Bradley A Officer - EVP Human Resources BUY $30.13 1,656 $49,890 48,340 +3.5%
2016-03-12 00:52 2016-03-09 LEVANGIE DANIEL J Officer - President, Drug Delivery OPT+S $30.89 12,299 $379,928 22,514 0.0%
2016-03-10 00:18 2016-03-07 LEVANGIE DANIEL J Officer - President, Drug Delivery SELL $31.15 7,663 $238,702 9,813 -43.8%
2016-03-03 15:42 2016-03-02 Hopfield Jessica Director BUY $30.91 3,230 $99,839 8,838 +57.6%
2015-08-25 00:45 2015-08-20 Thomas Bradley A Officer - EVP Human Resources BUY $29.41 845 $24,851 32,331 +2.7%
2015-06-08 14:19 2015-06-05 SULLIVAN PATRICK J Director, Officer - President & CEO BUY $29.39 10,000 $293,880 83,650 +13.6%
2015-05-29 00:59 2015-05-28 SULLIVAN PATRICK J Director, Officer - President & CEO BUY $27.91 20,000 $558,170 73,650 +37.3%
SHOW ENTRIES

How to Interpret $PODD Trades

Not every insider transaction in INSULET CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PODD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for PODD

Insider activity data for INSULET CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PODD, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.